Deferoxamine Mesylate

Deferoxamine Mesylate is a small molecule iron chelator that inhibits ferroptosis by sequestering free iron and reducing its accumulation. It is widely used in research to study iron overload, HIF-1α stabilization, and apoptosis in both cellular and animal models of diseases like cancer and neurodegeneration.

Product Specifications

CAS Number

138-14-7

Product Name Alternative

β Amyloid, βAmyloid, TAMSCs, SH-SY5Y, Iron, Mitophagy, neovascularization, Ferroptosis, HIF ProlylHydroxylase, HIF, HIF/HIFProlylHydroxylase, HIF Prolyl-Hydroxylase, HIF/HIF ProlylHydroxylase, HIFProlylHydroxylase, MEFs, Alzheimer's disease, b Amyloid, Autophagy, Amyloid-β, BMMSCs, bAmyloid, diabetes mellitus, DFOM, Desferrioxamine B mesylate, Deferoxamine, Deferoxamine Mesylate, COVID-19, Beta Amyloid, BetaAmyloid

Field of Research

Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction